Turbine Raises EUR 5.7M to Advance Simulation-first Oncology Pipeline
Share this article Share this article LONDON and BUDAPEST, Hungary, Jan. 7, 2021 /PRNewswire/ -- Turbine, a company simulating cellular decision making to unlock novel oncology therapies, today announces the successful closing of its pre-Series A round by raising EUR 5.7 million (USD 6.85m). The transatlantic round was led by new investor Accel and included XTX Ventures and Boston Millenia Partners who joined the existing syndicate comprising Delin Ventures, Atlantic Labs and o2h Ventures. Most wet-lab experiments offer limited insight into the complex underlying biology of the disease. As ...
Source: prnewswire.com